Literature DB >> 18393053

The color of meth: is it related to adverse health outcomes? An exploratory study in Tijuana, Mexico.

Steffanie A Strathdee1, Patricia Case, Remedios Lozada, Andrea R Mantsios, Jorge Alvelais, Minya Pu, Kimberly C Brouwer, Cari L Miller, Thomas L Patterson.   

Abstract

In a study of injection drug users (IDUs) in Tijuana, Mexico, logistic regression identified factors associated with injection of colored vs. clear methamphetamine in the prior six months (N = 613). Colors injected most often were clear (50%), white (47%), yellow (2%), and pink (1%). IDUs injecting colored meth were more likely to experience recent abscesses (34%) compared to those injecting clear meth (24%; p = 0.008), an association that persisted after adjusting for confounders. Market characteristics, possibly relating to purity or adulterants, may be associated with abscesses among methamphetamine injectors. Further study is needed to confirm and determine the mechanism of this association to better inform prevention messages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393053      PMCID: PMC3176304          DOI: 10.1080/10550490701862944

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  5 in total

Review 1.  Indicators of methamphetamine use and abuse in San Diego County, California: 2001-2005.

Authors:  Robin A Pollini; Steffanie A Strathdee
Journal:  J Psychoactive Drugs       Date:  2007-11

2.  Keratitis in methamphetamine abusers.

Authors:  E J Poulsen; M J Mannis; S D Chang
Journal:  Cornea       Date:  1996-09       Impact factor: 2.651

3.  Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico.

Authors:  Kimberly C Brouwer; Patricia Case; Rebeca Ramos; Carlos Magis-Rodríguez; Jesus Bucardo; Thomas L Patterson; Steffanie A Strathdee
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

4.  Identification of impurities and statistical classification of methamphetamine tablets (Ya-Ba) seized in Thailand.

Authors:  Vichet Puthaviriyakorn; Narinee Siriviriyasomboon; Juthamard Phorachata; Wiphada Pan-ox; Tetsuro Sasaki; Ken Tanaka
Journal:  Forensic Sci Int       Date:  2002-04-18       Impact factor: 2.395

5.  At the borders, on the edge: use of injected methamphetamine in Tijuana and Ciudad Juarez, Mexico.

Authors:  Patricia Case; Case Patricia; Rebeca Ramos; Kimberly C Brouwer; Michelle Firestone-Cruz; Robin A Pollini; Miguel A Fraga; Thomas L Patterson; Steffanie A Strathdee
Journal:  J Immigr Minor Health       Date:  2008-02
  5 in total
  5 in total

1.  Male injection drug users try new drugs following U.S. deportation to Tijuana, Mexico.

Authors:  Angela M Robertson; M Gudelia Rangel; Remedios Lozada; Alicia Vera; Victoria D Ojeda
Journal:  Drug Alcohol Depend       Date:  2011-08-10       Impact factor: 4.492

2.  High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico.

Authors:  Robin A Pollini; Manuel Gallardo; Samreen Hasan; Joshua Minuto; Remedios Lozada; Alicia Vera; María Luisa Zúñiga; Steffanie A Strathdee
Journal:  Int J Infect Dis       Date:  2010-04-08       Impact factor: 3.623

3.  Development of a risk reduction intervention to reduce bacterial and viral infections for injection drug users.

Authors:  Kristina T Phillips; Jennifer K Altman; Karen F Corsi; Michael D Stein
Journal:  Subst Use Misuse       Date:  2012-09-27       Impact factor: 2.164

4.  Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: results from the Clinical Trials Network.

Authors:  Daniel J Pilowsky; Li-Tzy Wu; Bruce Burchett; Dan G Blazer; George E Woody; Walter Ling
Journal:  Subst Abuse Rehabil       Date:  2011-01-01

5.  Prevalence and correlates of HIV among men who have sex with men in Tijuana, Mexico.

Authors:  Eileen V Pitpitan; David Goodman-Meza; Jose Luis Burgos; Daniela Abramovitz; Claudia V Chavarin; Karla Torres; Steffanie A Strathdee; Thomas L Patterson
Journal:  J Int AIDS Soc       Date:  2015-02-09       Impact factor: 5.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.